Bid to delay three-week AFT Pharmaceuticals trial declined

Bid to delay three-week AFT Pharmaceuticals trial declined
AFT Pharmaceuticals' managing director Hartley Atkinson is claiming PBL Solutions is taking against the NZX-listed company. (Image: Supplied)
Riley Kennedy
AFT Pharmaceuticals will face off against a former joint venture partner after the high court rejected a bid to delay the dispute's hearing until 2024.In the high court at Auckland, Justice Geoffrey Venning affirmed a three-week hearing between AFT and British Virgin Islands-based PBL Solutions will take place in October this year, bringing their two-year-old dispute to a head. PBL sought to have the case pushed out by 12 months, although the courts wouldn't have been able to hear it before 2024.While the judge rejected the applica...

More Markets

NZ sharemarket falls 1.2%
Markets Market close

NZ sharemarket falls 1.2%

The S&P/NZX 50 Index closed at 13,053.56 points, down 159.36 points or 1.21%.

Graham Skellern 28 Nov 2024
F&P Healthcare: don’t mention the tariffs!
Markets

F&P Healthcare: don’t mention the tariffs!

Mexican and Chinese plants could face tariffs on exports to the US.

Pattrick Smellie 28 Nov 2024
Steel & Tube says FY25 first four months challenging
Markets

Steel & Tube says FY25 first four months challenging

The company says the market has deteriorated.

Rebecca Howard 28 Nov 2024
TradeWindow raises run rate, narrows loss
Markets

TradeWindow raises run rate, narrows loss

Company remains on track for monthly breakeven in the first half of next year.

Pattrick Smellie 28 Nov 2024